Cargando…

Effect of transglutaminase 2 (TG2) deficiency on atherosclerotic plaque stability in the apolipoprotein E deficient mouse

BACKGROUND: Transglutaminase 2 (TG2), a cross-linking enzyme that confers supra-molecular structures with extra rigidity and resistance against proteolytic degradation, is expressed in the shoulder regions of human atherosclerotic plaques. It has been proposed that TG2 prevents tearing and promotes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Helen, Pease, Richard J., Newell, Laura M., Cordell, Paul A., Graham, Robert M., Kearney, Mark T., Jackson, Christopher L., Grant, Peter J.
Formato:	Texto
Lenguaje:	English
Publicado:	Elsevier 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874840/ https://www.ncbi.nlm.nih.gov/pubmed/20003977 http://dx.doi.org/10.1016/j.atherosclerosis.2009.11.014

Ejemplares similares

Visfatin Destabilizes Atherosclerotic Plaques in Apolipoprotein E–Deficient Mice
por: Li, Bo, et al.
Publicado: (2016)

Transglutaminase 2 limits the extravasation and the resultant myocardial fibrosis associated with factor XIII-A deficiency
por: Griffin, Kathryn J., et al.
Publicado: (2020)

Nkx2‐5 Is Expressed in Atherosclerotic Plaques and Attenuates Development of Atherosclerosis in Apolipoprotein E–Deficient Mice
por: Du, Meng, et al.
Publicado: (2016)

Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques
por: Baardman, Jeroen, et al.
Publicado: (2020)

Xyloketal B Attenuates Atherosclerotic Plaque Formation and Endothelial Dysfunction in Apolipoprotein E Deficient Mice
por: Zhao, Li-Yan, et al.
Publicado: (2015)

Pitavastatin Reduces Inflammation in Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice with Late Stage Renal Disease
por: Shibasaki, Manabu, et al.
Publicado: (2015)

Overexpression of Prolyl-4-Hydroxylase-α1 Stabilizes but Increases Shear Stress-Induced Atherosclerotic Plaque in Apolipoprotein E-Deficient Mice
por: Cao, Xiao-qing, et al.
Publicado: (2016)

Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice
por: Zheng, Fei, et al.
Publicado: (2014)

Protease-Activated Receptor-2 Deficiency Attenuates Atherosclerotic Lesion Progression and Instability in Apolipoprotein E-Deficient Mice
por: Zuo, Pengfei, et al.
Publicado: (2017)

Interleukin-17A influences the vulnerability rather than the size of established atherosclerotic plaques in apolipoprotein E-deficient mice
por: Wang, Bo, et al.
Publicado: (2022)

Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe(–/–) mice
por: Leipner, Julia, et al.
Publicado: (2021)

A cyclic azapeptide ligand of the scavenger receptor CD36/SR-B2 reduces the atherosclerotic lesion progression and enhances plaque stability in apolipoprotein E-deficient mice
por: Gauvin, Jade, et al.
Publicado: (2023)

Discovery and Characterization of PROTACs Targeting Tissue Transglutaminase (TG2)
por: Valdivia, Andres, et al.
Publicado: (2023)

ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions
por: Mantani, Polyxeni T., et al.
Publicado: (2019)

Overexpression of TGF-ß1 in Macrophages Reduces and Stabilizes Atherosclerotic Plaques in ApoE-Deficient Mice
por: Reifenberg, Kurt, et al.
Publicado: (2012)

Combinatorial interference of toll-like receptor 2 and 4 synergistically stabilizes atherosclerotic plaque in apolipoprotein E-knockout mice
por: Yang, Jian Min, et al.
Publicado: (2011)

Deficiency of Adipocyte IKKβ Affects Atherosclerotic Plaque Vulnerability in Obese LDLR Deficient Mice
por: Lu, Weiwei, et al.
Publicado: (2019)

Transglutaminase 2 moderates the expansion of mouse abdominal aortic aneurysms
por: Griffin, Kathryn J., et al.
Publicado: (2021)

Increased Osteoclastogenesis in Absence of TG2 Is Reversed by Transglutaminase Inhibition—Evidence for the Role for TG1 in Osteoclast Formation
por: Ebrahimi Samani, Sahar, et al.
Publicado: (2023)

The Fat-Fed Apolipoprotein E Knockout Mouse Brachiocephalic Artery in the Study of Atherosclerotic Plaque Rupture
por: Bond, Andrew R., et al.
Publicado: (2011)

Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease
por: Martucciello, Stefania, et al.
Publicado: (2020)

Acute perioperative-stress-induced increase of atherosclerotic plaque volume and vulnerability to rupture in apolipoprotein-E-deficient mice is amenable to statin treatment and IL-6 inhibition
por: Janssen, Henrike, et al.
Publicado: (2015)

Dystrophin deficiency reduces atherosclerotic plaque development in ApoE-null mice
por: Shami, Annelie, et al.
Publicado: (2015)

IL‐23R Deficiency Does Not Impact Atherosclerotic Plaque Development in Mice
por: Engelbertsen, Daniel, et al.
Publicado: (2018)

Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer
por: Mehta, Kapil, et al.
Publicado: (2011)

Neprilysin Inhibitor–Angiotensin II Receptor Blocker Combination Therapy (Sacubitril/valsartan) Suppresses Atherosclerotic Plaque Formation and Inhibits Inflammation in Apolipoprotein E- Deficient Mice
por: Zhang, Hui, et al.
Publicado: (2019)

The anti-inflammatory effects of exercise training promote atherosclerotic plaque stabilization in apolipoprotein E knockout mice with diabetic atherosclerosis
por: Kadoglou, N.P.E., et al.
Publicado: (2013)

Anti-tissue transglutaminase antibodies (TG2A) positivity and the risk of vitamin D deficiency among children - a cross-sectional study in the generation R cohort
por: van der Velde, Laura A., et al.
Publicado: (2023)

MicroRNA-33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE(−/−) Mice
por: Horie, Takahiro, et al.
Publicado: (2012)

Salidroside Decreases Atherosclerotic Plaque Formation in Low-Density Lipoprotein Receptor-Deficient Mice
por: Zhang, Bu-Chun, et al.
Publicado: (2012)

Tissue transglutaminase (TG2) activity regulates osteoblast differentiation and mineralization in the SAOS-2 cell line
por: Yin, Xiaoxue, et al.
Publicado: (2012)

Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN
por: Wang, Yi, et al.
Publicado: (2012)

LncRNAs as Regulators of Atherosclerotic Plaque Stability
por: Petkovic, Aleksa, et al.
Publicado: (2023)

Natural Killer T Cells Are Involved in Atherosclerotic Plaque Instability in Apolipoprotein-E Knockout Mice
por: Ohmura, Yoshinori, et al.
Publicado: (2021)

Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia
por: Zonca, Sara, et al.
Publicado: (2017)

Dihydroisoxazole inhibitors of Anopheles gambiae seminal transglutaminase AgTG3
por: Le, Binh V, et al.
Publicado: (2014)

Tanshinone II A stabilizes vulnerable plaques by suppressing RAGE signaling and NF-κB activation in apolipoprotein-E-deficient mice
por: Zhao, Dong, et al.
Publicado: (2016)

Nucleotide‐binding oligomerization domain protein 2 deficiency enhances CHOP expression and plaque necrosis in advanced atherosclerotic lesions
por: Kwon, Min‐Young, et al.
Publicado: (2020)

Evaluation of Plaque Stability of Advanced Atherosclerotic Lesions in Apo E-Deficient Mice after Treatment with the Oral Factor Xa Inhibitor Rivaroxaban
por: Zhou, Qianxing, et al.
Publicado: (2011)

TG2-gluten complexes as antigens for gluten-specific and transglutaminase-2 specific B cells in celiac disease
por: Lindstad, Christian B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_52eg7dsboiv243ai42hmq99v8e